Sodium ferulate has been shown to mitigate myocardial hypertrophy induced by abdominal aorta coarctation by inhibiting protein kinase C beta (PKC-β) and activating the MAPK signaling pathways (Luo et al., 2019). Here, PRKCB is linked to cardiac hypertrophy.